William Morey General Hospital (Chalon-sur-Saône)
Chalon-sur-Saône, Saône-et-Loire, 71100, France
NCT Number: NCT06216080
29.3% of bacteremias in intensive care units (ICU) are linked to vascular devices, with a significant proportion related to central venous catheters, and an influence on both morbility and mortality.
It is now accepted that microbiological biofilm plays a key role on both bacterial and fungal development on inner surface of vascular devices but there is yet a lack of clinical relevant data documenting a causal relation between biofilm formation and bacteremias.
We assume that a more precise characterization of central venous catheter-deposited biofilm could help us better understand invasive medical device-related healthcare infections in critically ill patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Chalon-sur-Saône, Saône-et-Loire, 71100, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Dynamic full-field optical coherence tomography analysis of central venous catheter sections to better apprehend strucural characterization of central venous catheter-deposited biofilm
Time frame: At Day 0, within 24h following catheter removal
Biofilm structure type (ribbon-shaped or mushroom-shaped), measured with D-FF-OCT
Time frame: At Day 0, within 24h following catheter removal
Biofilm thickness, measured with D-FF-OCT
Time frame: At Day 0, within 24h following catheter removal
Biofilm dynamic signal distribution, measured with D-FF-OCT
Centre Hospitalier William Morey - Chalon sur Saône
Other
Acronym: OCT-BIO-CVC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04192435
Anesthesia, Bleeding
Melbourne, Victoria, Australia
View Trial DetailsNCT03924934
Bacterial Infections, Bacterial Infections and Mycoses
Chapel Hill, North Carolina, United States
View Trial DetailsNCT04579094
Cross Infection, Disease Attributes
Nîmes, France
View Trial DetailsNCT05589727
Cross Infection, Disease Attributes
Barbalha, Ceará, Brazil
View Trial Details